Pharma News India

Indian pharma industry is expected to export products worth US$ 15.5 billion in FY 2012-13.

New Delhi, January 17, 2013: India is aiming to export pharmaceuticals worth US$ 15.5 billion in FY 2012-13 during the 2012-13 fiscal registering a growth of 17 per cent as compared to exports worth US$ 13.22 billion in 2011-12. At the same time, it is believes that the target of US$ 25 bil...


M&As expected in Indian pharma industry in 2013: Report

Mumbai, January 13, 2013: The Indian pharma industry is expected to see more action as far as the M&As in the industry is concerned during 2013, said a report from Avendus Securities.


The Indian pharmaceutical industry will register a growth of 19 per cent in 2013, says Morgan Stanley.

Mumbai, January 10, 2013: As per the recent report from Morgan Stanley, the Indian pharmaceutical industry will grow at 19 per cent in 2013.


The two companies have come together to develop new drugs for cancer.

New Delhi, January 9, 2013: The US-based Onconova Therapeutics and the contract research firm GVK Biosciences have entered into a joint partnership to develop new drugs for cancer.


Biocon is now permitted to market Itolizumab, a drug used in the treatment of psoriasis.

New Delhi, January 8, 2013: The biotechnology drug firm, Biocon, today said that the company has received approval from the drug controller, DCGI, to market its product Itolizumab, a drug used in the treatment of psoriasis.


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...